Last reviewed · How we verify

NCT07523412

Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft.

Not yet recruiting Phase 4 Last updated 15 April 2026
What this trial tests

Phase 4 trial testing Erythropoetin gel mixed with xenogenic bone graft in Peri-implant Bone and Soft Tissues in 26 participants. Not yet recruiting.

Timeline
12 April 2026
Primary endpoint
12 October 2026
12 November 2026

Quick facts

Lead sponsorAin Shams University
PhasePhase 4
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment26
Start date12 April 2026
Primary completion12 October 2026
Estimated completion12 November 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 20 to 50, any sex, with Peri-implant Bone and Soft Tissues. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted to compare the effect of Erythropoietin gel mixed with xenograft versus xenograft alone in grafting the jumping gap around immediate implant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07523412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing